(Q44620714)

4 December 2017

0 references

Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention (English)

1 reference

Cardiology and cardiovascular medicine

4 December 2017

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)01044-1

22 March 2024

1

John P A Ioannidis

1 reference

4 December 2017

Evangelia Karvouni

2

1 reference

4 December 2017

John P. A. Ioannidis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563583

22 March 2024

Demosthenes G. Katritsis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563583

22 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14563583

full work available at URL

22 March 2024

https://doi.org/10.1016/s0735-1097(03)01044-1

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563583

https://api.elsevier.com/content/article/PII:S0735109703010441?httpAccept=text/xml

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)01044-1

https://api.elsevier.com/content/article/PII:S0735109703010441?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)01044-1

Journal of the American College of Cardiology

22 March 2024

published in

1 reference

4 December 2017

42

1 reference

4 December 2017

8

1 reference

4 December 2017

1406-1411

1 reference

Recognition of the importance of embolization in atherosclerotic vascular disease

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Myonecrosis after revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Nothing is lower than 0, and 3 is closer to 0 than to 5 - medicine is not arithmetic.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Final results of the Balloon vs Optimal Atherectomy Trial (BOAT)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Prognostic implication of creatine kinase elevation following elective coronary artery interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Minimal myocardial damage during coronary intervention is associated with impaired outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Frequency and long-term impact of myonecrosis after coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901044-1

7 January 2021

Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)

series ordinal

4

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(03)01044-1

22 March 2024

Identifiers

1 reference

4 December 2017

1 reference